NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $63.4M
This Quarter Return
-2.15%
1 Year Return
+35.61%
3 Year Return
+215.98%
5 Year Return
–
10 Year Return
–
AUM
$93.7M
AUM Growth
+$93.7M
Cap. Flow
-$5.46M
Cap. Flow %
-5.83%
Top 10 Hldgs %
66.44%
Holding
48
New
3
Increased
5
Reduced
1
Closed
4

Top Buys

1
MRUS icon
Merus
MRUS
$1.81M
2
TRML icon
Tourmaline Bio
TRML
$1.62M
3
ZLAB icon
Zai Lab
ZLAB
$953K
4
LBPH
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$711K
5
BCYC
Bicycle Therapeutics
BCYC
$350K

Top Sells

1
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
$10.5M
2
NMRA icon
Neumora Therapeutics
NMRA
$871K
3
BCRX icon
BioCryst Pharmaceuticals
BCRX
$187K
4
DBVT
DBV Technologies
DBVT
$149K
5
GRTX
Galera Therapeutics, Inc. Common Stock
GRTX
$85.9K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ILMN icon
1
Illumina
ILMN
$15.8B
$12.4M 13.27%
119,196
– –
HRMY icon
2
Harmony Biosciences
HRMY
$2.12B
$11.1M 11.87%
368,665
– –
MRUS icon
3
Merus
MRUS
$4.98B
$7.1M 7.58%
120,038
+30,522
+34% +$1.81M
GERN icon
4
Geron
GERN
$893M
$5.82M 6.21%
1,373,550
+49,000
+4% +$208K
OCS icon
5
Oculis Holding
OCS
$844M
$5.21M 5.56%
436,378
– –
INCY icon
6
Incyte
INCY
$16.5B
$4.49M 4.79%
74,022
– –
EXAI
7
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$4.39M 4.68%
859,892
– –
XENE icon
8
Xenon Pharmaceuticals
XENE
$2.98B
$4.16M 4.44%
106,680
– –
LBPH
9
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$3.91M 4.17%
144,570
+26,315
+22% +$711K
MIRM icon
10
Mirum Pharmaceuticals
MIRM
$3.71B
$3.63M 3.87%
106,100
+10,000
+10% +$342K
LAB icon
11
Standard BioTools
LAB
$481M
$3.33M 3.56%
1,883,179
– –
ONC
12
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$3.28M 3.5%
23,022
– –
KALV icon
13
KalVista Pharmaceuticals
KALV
$678M
$2.58M 2.76%
219,277
– –
RYTM icon
14
Rhythm Pharmaceuticals
RYTM
$6.85B
$2.02M 2.15%
49,120
– –
TRML icon
15
Tourmaline Bio
TRML
$601M
$1.89M 2.01%
146,800
+125,813
+599% +$1.62M
RANI icon
16
Rani Therapeutics
RANI
$24.4M
$1.88M 2%
493,584
– –
ASND icon
17
Ascendis Pharma
ASND
$11.8B
$1.85M 1.98%
13,600
– –
REPL icon
18
Replimune Group
REPL
$422M
$1.84M 1.97%
204,939
– –
ACAD icon
19
Acadia Pharmaceuticals
ACAD
$4.38B
$1.67M 1.79%
102,984
– –
MDGL icon
20
Madrigal Pharmaceuticals
MDGL
$9.76B
$1.59M 1.7%
5,682
– –
EXEL icon
21
Exelixis
EXEL
$10.1B
$1.44M 1.54%
64,200
– –
ZLAB icon
22
Zai Lab
ZLAB
$3.68B
$953K 1.02%
+55,000
New +$953K
BMRN icon
23
BioMarin Pharmaceuticals
BMRN
$11.2B
$890K 0.95%
10,815
– –
BOLT icon
24
Bolt Biotherapeutics
BOLT
$9.85M
$875K 0.93%
1,166,952
– –
TRDA icon
25
Entrada Therapeutics
TRDA
$208M
$699K 0.75%
49,082
– –
1
2